Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Teaching statistical thinking to life scientists a case-based approach.

Philippe Vandenbroeck1, Luc Wouters, Geert Molenberghs

  • 1WS CVBA, Brussels, Belgium. philippe.vandenbroeck@ws-network.com

Journal of Biopharmaceutical Statistics
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of surrogate endpoints for survival outcomes using the surrogate package in R.

Computer methods and programs in biomedicine·2026
Same author

Integrating oral health screening into general practice: validation study of the Oral Health Screener.

Scientific reports·2026
Same author

Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases.

Statistics in medicine·2026
Same author

Handling Missing Data in Participants with Baseline but No Post-Baseline Data.

Pharmaceutical statistics·2026
Same author

A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2026
Same author

Predicting unplanned hospital revisits among community-dwelling older adults: a dynamic cohort study.

European journal of hospital pharmacy : science and practice·2025
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This workshop enhanced pharmaceutical research by improving data quality through structured approaches to bias and variability. It fostered collaboration between scientists and statisticians, promoting statistical thinking for better drug discovery outcomes.

Area of Science:

  • Pharmaceutical Sciences
  • Biostatistics
  • Research Methodology

Background:

  • Pharmaceutical discovery research often faces challenges with data quality due to bias and variability.
  • Effective collaboration between research scientists and statisticians is crucial for robust study design and analysis.
  • A common understanding of statistical principles is essential for bridging the gap between scientific inquiry and statistical rigor.

Purpose of the Study:

  • To enhance the quality of research data in pharmaceutical discovery.
  • To foster a more collaborative and informed relationship between scientists and statisticians.
  • To introduce and implement statistical thinking as a foundational element in pharmaceutical research.

Main Methods:

  • A workshop focused on statistical thinking tailored for scientists in pharmaceutical discovery.

Related Experiment Videos

  • Development of a structured approach to identify and manage bias and variability in research data.
  • Implementation of didactical methods to broaden the common understanding between scientists and statisticians.

    • Main Results:

    • Improved understanding and application of structured approaches to mitigate bias and variability.
    • Strengthened communication and collaboration between scientists and statisticians.
    • Enhanced integration of statistical thinking into the pharmaceutical discovery research process.

    Conclusions:

    • Workshops on statistical thinking are effective in improving data quality and research collaboration.
    • A structured approach to bias and variability, coupled with statistical thinking, benefits pharmaceutical discovery.
    • Bridging the gap between scientists and statisticians through shared understanding enhances research outcomes.